Cargando…
A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
SIMPLE SUMMARY: There is a need for additional marker(s) to detect early-stage ovarian cancer that would augment the performance of CA125. Herein, we report a polyamine signature that is detected in the blood and that has value for detecting ovarian cancers at an early stage. The polyamine signature...
Autores principales: | Fahrmann, Johannes F., Irajizad, Ehsan, Kobayashi, Makoto, Vykoukal, Jody, Dennison, Jennifer B., Murage, Eunice, Wu, Ranran, Long, James P., Do, Kim-Anh, Celestino, Joseph, Lu, Karen H., Lu, Zhen, Bast, Robert C., Hanash, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927060/ https://www.ncbi.nlm.nih.gov/pubmed/33671595 http://dx.doi.org/10.3390/cancers13040913 |
Ejemplares similares
-
c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy
por: Chen, Yihui, et al.
Publicado: (2023) -
Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
por: Park, Soyoung, et al.
Publicado: (2022) -
Plasma Based Protein Signatures Associated with Small Cell Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2021) -
Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
por: Kobayashi, Makoto, et al.
Publicado: (2020) -
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
por: León-Letelier, Ricardo A., et al.
Publicado: (2023)